IL163820A0 - Crystalline polymorphic form of irinotecan hydrochloride - Google Patents
Crystalline polymorphic form of irinotecan hydrochlorideInfo
- Publication number
- IL163820A0 IL163820A0 IL16382003A IL16382003A IL163820A0 IL 163820 A0 IL163820 A0 IL 163820A0 IL 16382003 A IL16382003 A IL 16382003A IL 16382003 A IL16382003 A IL 16382003A IL 163820 A0 IL163820 A0 IL 163820A0
- Authority
- IL
- Israel
- Prior art keywords
- polymorphic form
- irinotecan hydrochloride
- crystalline polymorphic
- crystalline
- irinotecan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36068402P | 2002-03-01 | 2002-03-01 | |
| PCT/EP2003/001948 WO2003074527A1 (en) | 2002-03-01 | 2003-02-26 | Crystalline polymorphic form of irinotecan hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163820A0 true IL163820A0 (en) | 2005-12-18 |
Family
ID=27789001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16382003A IL163820A0 (en) | 2002-03-01 | 2003-02-26 | Crystalline polymorphic form of irinotecan hydrochloride |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1487840B1 (de) |
| JP (1) | JP2005525367A (de) |
| KR (1) | KR20040091083A (de) |
| CN (1) | CN1276923C (de) |
| AR (1) | AR038618A1 (de) |
| AT (1) | ATE364610T1 (de) |
| AU (1) | AU2003215594A1 (de) |
| BR (1) | BR0308133A (de) |
| CA (1) | CA2477926A1 (de) |
| DE (1) | DE60314378T2 (de) |
| DK (1) | DK1487840T3 (de) |
| ES (1) | ES2287495T3 (de) |
| HK (1) | HK1075044A1 (de) |
| IL (1) | IL163820A0 (de) |
| MX (1) | MXPA04008484A (de) |
| NO (1) | NO20044138L (de) |
| NZ (1) | NZ534999A (de) |
| PE (1) | PE20030923A1 (de) |
| PL (1) | PL372318A1 (de) |
| PT (1) | PT1487840E (de) |
| RU (1) | RU2300535C2 (de) |
| TW (1) | TWI270374B (de) |
| WO (1) | WO2003074527A1 (de) |
| ZA (1) | ZA200406927B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004215560B2 (en) * | 2003-02-25 | 2009-09-24 | Kabushiki Kaisha Yakult Honsha | Method for preparing polymorphism of irinotecan hydrochloride |
| ES2245891B1 (es) * | 2004-07-09 | 2006-11-16 | Clinmet S.L. | "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo". |
| DK1828196T3 (da) | 2004-12-21 | 2012-11-26 | Sigma Tau Ind Farmaceuti | Stereospecifik fremgangsmåde og krystallinske former af en camptothecin |
| ATE446299T1 (de) | 2005-02-07 | 2009-11-15 | Fermion Oy | Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin |
| ES2430375T3 (es) | 2005-02-08 | 2013-11-20 | Fermion Oy | Procedimiento para la producción de cloruro de [1,4']bipiperidinil-1'-carbonilo o su clorhidrato |
| JP5133704B2 (ja) * | 2005-02-08 | 2013-01-30 | フェルミオン オサケ ユキチュア | 製造方法 |
| EP1951235B1 (de) * | 2005-09-20 | 2010-03-10 | Scinopharm Singapore Pte, Ltd. | Neue kristallformen von irinotecan-hydrochlorid |
| CN101318964B (zh) * | 2007-06-07 | 2010-12-15 | 上海迪赛诺医药发展有限公司 | 盐酸伊立替康新晶型及其制备方法 |
| FR2918279B1 (fr) * | 2007-07-05 | 2010-10-22 | Aventis Pharma Sa | Combinaisons antitumorales contenant un agent inhibiteur de vegf et de l'irinotecan |
| IT1391757B1 (it) * | 2008-11-11 | 2012-01-27 | Antibioticos Spa | Irinotecan cloridrato cristallino e metodi per la sua preparazione |
| CN101659667B (zh) * | 2009-09-07 | 2011-11-02 | 重庆泰濠制药有限公司 | 一种盐酸伊立替康的纯化方法 |
| US8546573B2 (en) | 2009-11-18 | 2013-10-01 | Cadila Healthcare Limited | Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| CN102866126B (zh) * | 2011-07-05 | 2016-03-23 | 重庆华邦制药有限公司 | 一种定量测定化合物中晶型比例的方法 |
| CN102311443B (zh) * | 2011-08-24 | 2014-07-16 | 上海北卡医药技术有限公司 | 盐酸伊立替康的新晶型及其制备方法 |
| RU2529831C2 (ru) * | 2012-11-30 | 2014-09-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) | Способ лечения рака толстой кишки |
| EA035674B1 (ru) | 2014-07-18 | 2020-07-24 | Санофи | Способ определения того, является ли пациент, предположительно страдающий от рака, кандидатом для терапии афлиберцептом |
| KR102293907B1 (ko) | 2015-06-30 | 2021-08-26 | 한미약품 주식회사 | 이리노테칸 함유 경구용 고형제제 및 그 제조방법 |
| KR102066402B1 (ko) * | 2017-12-22 | 2020-01-15 | 대화제약 주식회사 | 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물 |
| US10919905B2 (en) * | 2019-05-16 | 2021-02-16 | Scinopharm Taiwan, Ltd. | Polymorphism for irinotecan free base |
-
2003
- 2003-02-26 PT PT03743335T patent/PT1487840E/pt unknown
- 2003-02-26 PL PL03372318A patent/PL372318A1/xx not_active Application Discontinuation
- 2003-02-26 WO PCT/EP2003/001948 patent/WO2003074527A1/en active IP Right Grant
- 2003-02-26 NZ NZ534999A patent/NZ534999A/en unknown
- 2003-02-26 RU RU2004129307/04A patent/RU2300535C2/ru not_active IP Right Cessation
- 2003-02-26 DK DK03743335T patent/DK1487840T3/da active
- 2003-02-26 BR BR0308133-8A patent/BR0308133A/pt not_active IP Right Cessation
- 2003-02-26 MX MXPA04008484A patent/MXPA04008484A/es not_active Application Discontinuation
- 2003-02-26 JP JP2003572995A patent/JP2005525367A/ja not_active Withdrawn
- 2003-02-26 IL IL16382003A patent/IL163820A0/xx unknown
- 2003-02-26 CA CA002477926A patent/CA2477926A1/en not_active Abandoned
- 2003-02-26 ES ES03743335T patent/ES2287495T3/es not_active Expired - Lifetime
- 2003-02-26 DE DE60314378T patent/DE60314378T2/de not_active Expired - Fee Related
- 2003-02-26 AT AT03743335T patent/ATE364610T1/de not_active IP Right Cessation
- 2003-02-26 AU AU2003215594A patent/AU2003215594A1/en not_active Abandoned
- 2003-02-26 EP EP03743335A patent/EP1487840B1/de not_active Expired - Lifetime
- 2003-02-26 CN CNB038072726A patent/CN1276923C/zh not_active Expired - Fee Related
- 2003-02-26 KR KR10-2004-7013621A patent/KR20040091083A/ko not_active Application Discontinuation
- 2003-02-27 TW TW092104194A patent/TWI270374B/zh not_active IP Right Cessation
- 2003-02-28 AR ARP030100656A patent/AR038618A1/es unknown
- 2003-02-28 PE PE2003000196A patent/PE20030923A1/es not_active Application Discontinuation
-
2004
- 2004-08-31 ZA ZA200406927A patent/ZA200406927B/en unknown
- 2004-09-29 NO NO20044138A patent/NO20044138L/no not_active Application Discontinuation
-
2005
- 2005-08-22 HK HK05107303A patent/HK1075044A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1642958A (zh) | 2005-07-20 |
| EP1487840B1 (de) | 2007-06-13 |
| CN1276923C (zh) | 2006-09-27 |
| PL372318A1 (en) | 2005-07-11 |
| TW200303753A (en) | 2003-09-16 |
| KR20040091083A (ko) | 2004-10-27 |
| EP1487840A1 (de) | 2004-12-22 |
| NZ534999A (en) | 2007-03-30 |
| CA2477926A1 (en) | 2003-09-12 |
| NO20044138L (no) | 2004-11-29 |
| BR0308133A (pt) | 2005-01-04 |
| ES2287495T3 (es) | 2007-12-16 |
| PT1487840E (pt) | 2007-09-11 |
| WO2003074527A1 (en) | 2003-09-12 |
| ZA200406927B (en) | 2006-06-28 |
| PE20030923A1 (es) | 2003-10-29 |
| AU2003215594A1 (en) | 2003-09-16 |
| DE60314378D1 (en) | 2007-07-26 |
| JP2005525367A (ja) | 2005-08-25 |
| AR038618A1 (es) | 2005-01-19 |
| RU2300535C2 (ru) | 2007-06-10 |
| TWI270374B (en) | 2007-01-11 |
| MXPA04008484A (es) | 2004-12-06 |
| RU2004129307A (ru) | 2005-04-10 |
| HK1075044A1 (en) | 2005-12-02 |
| DK1487840T3 (da) | 2007-07-16 |
| ATE364610T1 (de) | 2007-07-15 |
| DE60314378T2 (de) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1075044A1 (en) | Crystalline polymorphic form of irinotecan hydrochloride | |
| HK1093483A1 (en) | Polymorphic form of n- | |
| SI1608634T1 (sl) | Postopki za izoliranje kristalinične oblike I 5-azacitidina | |
| IL172006A0 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| EP1773339A4 (de) | Kristalline form von donepezil-hydrochlorid | |
| HU0200438D0 (en) | Novel clopidogrel hydrochloride polymorphs | |
| HK1094190A1 (en) | a polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline | |
| IL160721A0 (en) | Crystalline forms of valacyclovir hydrochloride | |
| IL170350A (en) | Method for preparing polymorphism of irinotecan hydrochloride | |
| HK1067123A1 (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation | |
| IL192360A0 (en) | Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation | |
| AU2003245029A1 (en) | Novel crystalline forms of donepezil hydrochloride | |
| EP1628664A4 (de) | Polymorphe formen von naltrexon | |
| AU2003245027A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
| IL166592A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003232719A1 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| IL165115A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003248657A1 (en) | Polymorphic form xvi of fexofenadine hydrochloride | |
| AU2003289995A1 (en) | Anhydrous crystalline form of valacyclovir hydrochloride | |
| AU2003250086A1 (en) | Crystalline polymorphic and amorphous forms of benazepril hydrochloride | |
| IL174969A0 (en) | Crystalline forms of (+)-and (-) erythro-mefloquine hydrochloride | |
| SI1487840T1 (sl) | Kristalinična polimorfna oblika irinotekan hidroklorida | |
| IL165690A0 (en) | Novel crystalline forms of gatifloxacin | |
| IL174063A0 (en) | Crystalline form of gatifloxacin | |
| PL376832A1 (pl) | Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny |